Anti-HIV Fast Test Kit

Anti-HIV Fast Test Kit

Anti-HIV Fast Test Kit by GP Diagnostics is a quantitative immunofluorescence assay for detecting HIV antibodies in serum or plasma. Provides accurate results in 15 minutes to aid early HIV diagnosis and monitoring of AIDS progression.

Description

Anti-HIV Fast Test Kit (Immunofluorescence Assay)

The Anti-HIV Fast Test Kit is a quantitative immunofluorescence assay for detecting antibodies against the Human Immunodeficiency Virus (HIV) in serum or plasma samples. This test supports early diagnosis, prognosis evaluation, and ongoing monitoring of acquired immunodeficiency syndrome (AIDS) in clinical settings.

Key Advantages

  • Quantitative Detection: Measures anti-HIV antibodies with high sensitivity and precision
  • Rapid Testing: Delivers results in just 15 minutes
  • Minimal Sample Volume: Requires only 100 µL of serum or plasma
  • Reliable Technology: Utilizes immunofluorescence assay for accurate and consistent results
  • Stable Storage: Store at 4–30°C with a shelf life of 24 months

About HIV

Human Immunodeficiency Virus (HIV) is the causative agent of Acquired Immunodeficiency Syndrome (AIDS). Within weeks of infection, individuals typically experience an acute flu-like illness as viral replication peaks in the blood. Detecting HIV antibodies early is essential for timely intervention and management of the disease progression.

Specifications

Parameter Details
Test Item HIV Antibody
Sample Type Serum, Plasma
Sample Volume 100 µL
Detection Method Immunofluorescence Assay
Detection Range 1.00–1000.00 S/CO
Test Time 15 Minutes
Storage Conditions 4–30°C
Shelf Life 24 Months

Compatible Devices

  • Getein 1100 Immunofluorescence Quantitative Analyzer
  • Getein 1160 Immunofluorescence Quantitative Analyzer
  • Getein 1180 Immunofluorescence Quantitative Analyzer
  • Getein 1200 Immunofluorescence Quantitative Analyzer
  • Getein 1600 Immunofluorescence Quantitative Analyzer

Clinical Applications

  • Aid in the diagnosis of HIV infection and AIDS
  • Monitoring HIV disease progression and treatment response
  • Support in screening high-risk populations